We have shown that i.n. immunization with our multivalent ChAd:TB vaccine induces long-lasting tissue-resident memory CD4+ and CD8+ T cells against Ag85A, TB10.4, and RpfB within the airways which are further boosted quantitively and qualitatively in s.c. BCG-primed hosts. Here, CD8A is linked to tuberculosis.